The investigators found that Candida albicans
in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 per cent survival rate compared to a 25 per cent survival rate in mice who did not receive the treatment.
exhibited the lowest values of MIC (19.5 [micro]g/mL).
Increasing emergence and spread of various non albicans
candida is a major concern in the management of VVC.
Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans
. The Journal of Antimicrobial Chemotherapy, vol.
For antifungal susceptibility testing, initially the isolated Candida albicans
were screened by disc diffusion method and resistant strains further identified by dilution method.
tambien produce prostaglandinas (33) y que con la administracion de inhibidores de la ciclooxigenasa disminuye esta produccion y la viabilidad de la levadura (36).
Out of 41 Candida albicans
isolates, 21 (51.2%) strains were positive for biofilm production.
was inoculated to 0.1 [OD.sub.600] to both control and MB treated cells and allowed to grow till the [OD.sub.600] reaches 1.0.
Sobel, "Fluconazole-resistant candida albicans
vulvovaginitis," Obstetrics & Gynecology, vol.
that reduced motility to 94% (MCA-0.05 McF, p<0.0001) while C.
at time intervals T0 and T1 is shown in Table 2.
(n = 14, 30%), followed by Candida tropicalis (n = 10, 21%), Candida glabrata (n = 9, 19%), Candida lusitaniae (n = 9, 19%), and Candida parapsilosis (n = 5, 11%) as depicted in Table 2.
is the leading yeast involved in fungal infections in the world, though other species start to detach, this species still remains isolated from samples of urine, blood, secretions, among other biological samples (Quindos, 2014).
remains the leading cause of candidiasis worldwide (6-9).